Business Context and Reporting Period
Biote Corp. filed this Form 8-K on March 28, 2023, under Item 2.02 to announce financial results for the quarter and fiscal year ended December 31, 2022. The filing furnishes a related press release as Exhibit 99.1; the press release text is not included in the provided filing content.
Financial Metrics
The provided Form 8-K does not state clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics. These amounts may be contained in Exhibit 99.1, which is referenced but not provided.
Material Changes Versus the Prior Comparable Period
The filing text does not provide a clear comparison with the prior-year quarter or fiscal year.
Guidance, Outlook, Risks, and Unusual Items
- The filing does not provide guidance, outlook commentary, risk updates, contingencies, or unusual-item disclosures in the text supplied.
- The reported information is furnished under Item 2.02 and is not deemed filed for purposes of Section 18 of the Exchange Act, nor incorporated by reference into other filings unless expressly stated.
- Biote Corp. identified itself as an emerging growth company.
Investor Verification Items
- Obtain and review Exhibit 99.1 for the complete financial results and management commentary.
- Verify revenue, profitability, cash flow, margins, debt, cash, liquidity, and any non-GAAP measures against the company’s financial statements.
- Review year-over-year changes, forward guidance, and any disclosures regarding risks or unusual items.